Commercial Metals

Commercial Metals

Yahoo Finance • 4 days ago

Elmet (ELMT) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 13, 2026 at 9:00 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer - Peter V. Anania Chief Financial Officer - Michael Lee Full Conference Call Transcript Operator: Good... Full story

Yahoo Finance • 5 days ago

Tentative trade deal would cut Canada steel, aluminum tariffs by half - reports

[Following Shot of Heavy Industry Engineers Walking Through Manufacturing Factory. In the Background Professionals Working on Construction of Oil, Gas and Fuel Pipeline Transportation Products] gorodenkoff/iStock via Getty Images The U.S.... Full story

Yahoo Finance • 5 days ago

PolyPid (PYPD) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 12, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chief Executive Officer - Dikla Czaczkes Akselbrad Chief Financial Officer - Jonny Missulawin Chief Operating Officer, U.S. - Ori Warshavsky... Full story

Yahoo Finance • 10 days ago

Is Scholar Rock Holding Corporation (SRRK) Better Positioned than Novo Nordisk A/S (NVO) After Recent Setbacks?

Two healthcare players, Scholar Rock Holding Corporation (NASDAQ:SRRK) and Novo Nordisk A/S (NYSE:NVO), find their near-term narratives intertwined over manufacturing compliance. One is smoothly navigating a supply chain hurdle ahead of a... Full story

Yahoo Finance • 11 days ago

Ocugen (OCGN) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 8:30 a.m. ET CALL PARTICIPANTS Chairman, Chief Executive Officer, and Co-Founder - Shankar MusunuriChief Financial Officer - Rita Johnson-GreeneExecutive Vice President of C... Full story

Yahoo Finance • 11 days ago

Elmet Group Q2 Earnings Call Highlights

Key Points Interested in Elmet Group Co.? Here are five stocks we like better. Strong second-quarter growth: Revenue rose 35.2% to $66.4 million, while gross profit increased 63.7% and gross margin expanded to 25.0%. Adjusted EBITDA climb... Full story

Yahoo Finance • 11 days ago

PTC Expands Rare Disease Portfolio With ST-920 Acquisition

(RTTNews) - PTC Therapeutics, Inc., (PTCT) has agreed to acquire ST-920, a BLA-stage one-time AAV gene therapy for Fabry disease from Sangamo Therapeutics in a $111 million upfront deal plus milestone payments. Fabry disease is a rare inh... Full story

Yahoo Finance • 11 days ago

Longeveron expects ELPIS II HLHS data in mid-september while cash runway extends into Q4 2026

Earnings Call Insights: Longeveron (LGVN) Q2 2026 MANAGEMENT VIEW * "Longeveron is approaching a series of potentially transformative milestones across our 4 stem cell therapy development programs" (CEO & Director Stephen Willard), whi... Full story

Yahoo Finance • 12 days ago

Inovio (INO) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Aug. 12, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Director of Communications - Jennie WillsonPresident and Chief Executive Officer - Dr. Jacqueline E. SheaChief Medical Officer - Dr. Michael... Full story

Yahoo Finance • 14 days ago

Stoke Therapeutics (STOK) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Monday, Aug. 3, 2026 at 4:30 p.m. ET CALL PARTICIPANTS Chief Financial Officer - Thomas LeggettChief Executive Officer - Ian SmithChief Medical Officer - Barry TichoChief Patient Officer - Jason Hoit... Full story

Yahoo Finance • 14 days ago

Hormuz risk premium: Who wins and loses in the tanker trade

[The tanker] Dikuch/iStock via Getty Images INVESTORS SHOULD KNOW: The Strait of Hormuz remains a live flashpoint for global oil markets, with Iran-Oman shipping talks nearing completion but full reopening still tied to unresolved U.S.-Ir... Full story

Yahoo Finance • 16 days ago

Koppers Q2 Earnings Call Highlights

Key Points Interested in Koppers Holdings Inc.? Here are five stocks we like better. Koppers lowered its 2026 adjusted EBITDA outlook to $240 million–$250 million from ongoing cost pressures, particularly higher coal tar, freight and logi... Full story

Yahoo Finance • 17 days ago

Anika (ANIK) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, July 29, 2026 at 8:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer - Stephen D. GriffinSenior Vice President, Chief Accounting Officer, and Treasurer - Ian W. McLeodExec... Full story

Yahoo Finance • 17 days ago

FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval

FDA identified no major deficiencies related to the ketamine drug product, ingredients, proposed labeling, CMC, or other drug-related review matters.Remaining item relates to manufacturer certification for a luer lock vial already used in... Full story

Yahoo Finance • 18 days ago

Regenxbio Inc (RGNX) (Q2 2026) Earnings Call Highlights: Cash Runway Extended into Q4 2027 on ...

This article first appeared on GuruFocus. Cash Position: Ended Q2 2026 with cash, equivalents, and marketable securities of $106 million. Pro Forma Cash: More than $310 million after receiving a $100 million milestone payment from AbbVie... Full story

Yahoo Finance • 18 days ago

Actimed Therapeutics Reacquires Global Rights to S-oxprenolol, Broadening Pipeline Opportunity

London, UK – 6th August 2026. Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage       specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and other muscle wasting disorders, ann... Full story

Yahoo Finance • 19 days ago

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Advances to Expansion Phase in First-Line Hepatocellular Carcinoma Following Positive Efficacy Signals

NANJING, China, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that its Phase II clinical study evaluating Opamtistomig (LBL-024), a proprietary P... Full story

Yahoo Finance • 19 days ago

Eli Lilly and Co (LLY) (Q2 2026) Earnings Call Highlights: Revenue Surges 48% on Zepbound and ...

This article first appeared on GuruFocus. Revenue: Grew 48% compared to Q2 2025, driven by Zepbound and Mounjaro. Gross Margin: 86.3% of revenue, an increase of approximately 1.3 percentage points versus the same quarter last year. Market... Full story

Yahoo Finance • 19 days ago

Geron Corporation Q2 2026 Earnings Call Summary

Geron Corporation Q2 2026 Earnings Call Summary - Moby Strategic Execution and Commercial Momentum Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 p... Full story

Yahoo Finance • 19 days ago

Geron Q2 Earnings Call Highlights

Key Points Interested in Geron Corporation? Here are five stocks we like better. Geron reported strong second-quarter performance, with revenue rising 17% year over year to $57.5 million and first-half revenue up approximately 24%. The co... Full story